Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Aggressive antihypertensive strategies based on hydrochlorothiazide, candesartan or lisinopril decrease left ventricular mass and improve arterial compliance in patients with type II diabetes mellitus and hypertension.

Spoelstra-de Man AM, van Ittersum FJ, Schram MT, Kamp O, van Dijk RA, Ijzerman RG, Twisk JW, Brouwer CB, Stehouwer CD.

J Hum Hypertens. 2006 Aug;20(8):599-611. Epub 2006 May 4.

PMID:
16673014
3.
4.

Effects of candesartan and lisinopril on the fibrinolytic system in hypertensive patients.

Hirschl MM, Bur A, Woisetschlaeger C, Derhaschnig U, Laggner AN.

J Clin Hypertens (Greenwich). 2007 Jun;9(6):430-5.

5.

Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.

Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.

Clin Ther. 2007 Feb;29(2):279-89.

PMID:
17472820
6.

Antihypertensive efficacy of candesartan-lisinopril in combination vs. up-titration of lisinopril: the AMAZE trials.

Izzo JL Jr, Weinberg MS, Hainer JW, Kerkering J, Tou CK; AMAZE.

J Clin Hypertens (Greenwich). 2004 Sep;6(9):485-93.

7.

Pulse pressure lowering effect of dual blockade with candesartan and lisinopril vs. high-dose ACE inhibition in hypertensive type 2 diabetic subjects: a CALM II study post-hoc analysis.

Knudsen ST, Andersen NH, Poulsen SH, Eiskjaer H, Hansen KW, Helleberg K, Poulsen PL, Mogensen CE.

Am J Hypertens. 2008 Feb;21(2):172-6. doi: 10.1038/ajh.2007.2. Epub 2008 Jan 10.

PMID:
18188164
9.

Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.

Devereux RB, de Faire U, Fyhrquist F, Harris KE, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Hille DA, Dahlöf B.

Curr Med Res Opin. 2007 Feb;23(2):259-70.

PMID:
17288679
12.

Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy.

Tarnow L, Sato A, Ali S, Rossing P, Nielsen FS, Parving HH.

Diabetes Care. 1999 Mar;22(3):491-4.

14.

Long-term effects of a renin inhibitor versus a thiazide diuretic on arterial stiffness and left ventricular diastolic function in elderly hypertensive patients.

Okada Y, Shibata S, Fujimoto N, Best SA, Levine BD, Fu Q.

Am J Physiol Regul Integr Comp Physiol. 2017 Oct 1;313(4):R400-R409. doi: 10.1152/ajpregu.00125.2017. Epub 2017 Jul 19.

PMID:
28724547
15.

Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).

Papademetriou V, Farsang C, Elmfeldt D, Hofman A, Lithell H, Olofsson B, Skoog I, Trenkwalder P, Zanchetti A; Study on Cognition and Prognosis in the Elderly study group.

J Am Coll Cardiol. 2004 Sep 15;44(6):1175-80.

16.

Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension. Losartan Trial Investigators.

Manolis AJ, Grossman E, Jelakovic B, Jacovides A, Bernhardi DC, Cabrera WJ, Watanabe LA, Barragan J, Matadamas N, Mendiola A, Woo KS, Zhu JR, Mejia AD, Bunt T, Dumortier T, Smith RD.

Clin Ther. 2000 Oct;22(10):1186-203.

PMID:
11110230
17.
19.

Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa.

Sareli P, Radevski IV, Valtchanova ZP, Libhaber E, Candy GP, Den Hond E, Libhaber C, Skudicky D, Wang JG, Staessen JA.

Arch Intern Med. 2001 Apr 9;161(7):965-71.

PMID:
11295959
20.

Effects of amlodipine and lisinopril on left ventricular mass and diastolic function in previously untreated patients with mild to moderate diastolic hypertension.

Beltman FW, Heesen WF, Smit AJ, May JF, de Graeff PA, Havinga TK, Schuurman FH, van der Veur E, Lie KI, Meyboom-de Jong B.

Blood Press. 1998 May;7(2):109-17.

PMID:
9657538

Supplemental Content

Support Center